Prof Stricker’s unit at St Vincent’s and the Kinghorn Cancer Centre has been appointed the Asia-Pacific region training centre for NanoKnife therapy. Professor Stricker’s team at St Vincent’s Hospital has now been appointed as the Asia-Pacific region training site for the development of NanoKnife treatments. Stricker and his team have now performed over 200 cases. During this period […]
NanoKnife (IRE) for localised prostate cancer Read More »
Prof Stricker’s team has published the world’s first report of cancer outcomes following focal NanoKnife therapy for focal prostate cancer. This appeared in October’s 2015 edition of Prostate and Prostatic Diseases. Prof Stricker’s is one of the few centres in the world evaluating this technology as focal therapy for localised prostate cancer. This therapy is
Focal Therapy for Prostate Cancer Read More »
Prof Stricker’s team has now presented the results of the key studies on mMRI of the Prostate by invitation in Australia, USA and Europe. His team have demonstrated it’s accuracy but cautions about how long it takes to develop the expertise to develop this accuracy. It has been shown that a negative MRI is 97%
MRI Prostate Imaging Read More »
Minh Tran, one of Prof Stricker’s fellows, recently presented the results at the American meeting on how to select patients for focal therapy using a high-quality multiparametric MRI and transperineal biopsy. It was shown that in appropriate cases one could be confident of patient selection. It was felt that approximately 20% of patients who came
Selection of patients for focal therapy Read More »
Prof Stricker and A/Prof Emmett have recently published a study comparing PSMA PET/CT scan to the more established Choline PET-CT scan. It confirmed that PSMA PET/CT scaning is much more accurate. Prof Stricker is now conducting trials looking at patients with high-risk cancers using this new PET scanning to allow more appropriate therapy, particularly in high-volume,
PSMA PET/CT Scan Accuracy Read More »
Prof Stricker has introduced a new procedure for benign enlargement of the prostate to enable improvement in urinary function without affecting sexual function. The first case was performed at St Vincent’s in April 2015 and all patients were treated as day patients. The treatment involves placing, at the time of cystoscopy, some needle placements to
The UroLift Procedure Read More »
Prof Stricker presented MRI and focal therapy results at the recent American Urological Association Annual Meeting. MRI was the most topical area at this meeting. His results confirmed the accuracy of multiparametric MRI of the prostate in highly experienced hands. Prof Stricker’s results confirmed the accuracy of multiparametric MRI of the prostate in highly experienced
MRI and focal therapy at the recent American Urological Association Read More »
Prof Stricker was invited to be the visiting professor at the University Hospitals Case Medical Centre, Case Western Reserve School of Medicine, Cleveland, Ohio for 2105. Whilst there he spoke about focal therapy, magnetic resonance imaging, robotic prostate surgery and his extensive experience in transperineal biopsy. The talks were very well received by the faculty
Visiting professor at the University Hospitals Case Medical Centre, Cleveland, Ohio. Read More »
Prof Stricker, the chief investigator on the current Active Surveillance trial, said that the trial is running extremely well and accruing valuable data rapidly. This trial is to assess the role of MRI in monitoring patients on active surveillance instead of using the traditional technique of biopsy. Biopsies will be used but
Active surveillance trial Read More »
For distinguished service to medicine and medical research, as a leading urologist, a robotic surgery pioneer, a teacher and mentor, and as an advocate for prostate cancer awareness. When asked about being made an Officer of the Order of Australia, Stricker responded, “This is a really nice endorsement of our work but we have a
Professor Stricker awarded an AO Read More »
Prof Stricker and Louise Emmett have been instrumental in beginning a choline PET scan imaging which allows patients to find microscopic disease in lymph glands beyond the prostate. This has been very helpful in people where the PSA starts rising after surgery or radiotherapy to locate the problem so that we can target it and
New forms of imaging now offered at St Vincent’s Read More »
A recent publication by Prof Stricker’s and Prof Emberton’s group in the journal Prostate Cancer and Prostate Diseases confirmed the safety of NanoKnife focal therapy in prostate cancer. Prof Stricker feels that this is a major advance in focal therapy as irreversible electroporation has significant potential advantages over all the other energy sources currently used
The ABC recently reported on the use of MRI in testing for prostate cancer. The story focusses on the St Vincent’s study that looked at 150 men over the age of 40 with positive PSA tests. The average age was 62 years old and they all had MRI scans. Professor Phillip Stricker authored the study and
MRI scans could be a ‘game-changer’ in prostate cancer testing Read More »
Prof Stricker now has perfected the technique of MR-ultrasound fusion biopsies using the safe transperineal technique but using the technology of MRI’s for accurate localisation. Using the Biojet system, Prof Stricker has perfected he technique of MR-ultrasound fusion biopsies, having now performed over 100. He confirmed that the MRI allows for accurate localisation. The procedure is
Accuracy and safety of MRI/US targeted biopsies confirmed Read More »
Dr Stricker’s research group has recently published research on the outcomes of patients having MRI prior to biopsy. It was proven that the approach was very useful and the technology was dependable and highly accurate. They found that if the MRI was clear, there was a 97% chance of not having a significant cancer. If
The value of MRI before biopsy Read More »
